Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Furrer

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
HIV Medicine|March 25, 2018
Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with menK Aebi-Popp, G Wandeler, L Salazar-Vizcaya, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 9, 2019
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort studyL Boschung-Pasquier, A Atkinson, L K Kastner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
HIV Medicine|November 10, 2015
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive personsL Ryom, C Boesecke, V Gisler, et al.
Lancet (London, England)|December 16, 2000
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyG Greub, B Ledergerber, M Battegay, et al.
Therapeutische Umschau. Revue Therapeutique|July 10, 2001
[Malaria--chemoprophylaxis 2001]F R Hatz, B Beck, J Blum, et al.
HIV Medicine|March 2, 2017
Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort StudyH M Gebreselassie, D Kraus, C A Fux, et al.
HIV Medicine|July 3, 2015
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptakeV Schaerer, S Haubitz, H Kovari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2024
Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort StudyM S R Weber, J J Duran Ramirez, M Hentzien, et al.
HIV Clinical Trials|April 19, 2012
Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissueS M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
HIV Medicine|March 25, 2018
Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with menK Aebi-Popp, G Wandeler, L Salazar-Vizcaya, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 9, 2019
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort studyL Boschung-Pasquier, A Atkinson, L K Kastner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
HIV Medicine|November 10, 2015
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive personsL Ryom, C Boesecke, V Gisler, et al.
Lancet (London, England)|December 16, 2000
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyG Greub, B Ledergerber, M Battegay, et al.
Therapeutische Umschau. Revue Therapeutique|July 10, 2001
[Malaria--chemoprophylaxis 2001]F R Hatz, B Beck, J Blum, et al.
HIV Medicine|March 2, 2017
Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort StudyH M Gebreselassie, D Kraus, C A Fux, et al.
HIV Medicine|July 3, 2015
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptakeV Schaerer, S Haubitz, H Kovari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2024
Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort StudyM S R Weber, J J Duran Ramirez, M Hentzien, et al.
HIV Clinical Trials|April 19, 2012
Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissueS M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
Pageof 10